Submission of certificate under regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended on 31st March, 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Evoq Remedies Limited has submitted a routine compliance certificate to BSE for the quarter ended 31st March 2025. The filing is made under Regulation 74(5) of SEBI's Depositories and Participants Regulations, 2018, and contains a confirmation certificate received from the company's Registrar and Share Transfer Agent, Accurate Securities & Registry Private Limited. This certificate confirms that dematerialized securities (shares held in electronic/Demat form) have been properly processed and reconciled during the quarter. The letter is signed by Managing Director Bhumishth Patel (DIN: 02516641) and was digitally signed on 11th April 2025. No financial figures, business updates, or material changes are disclosed in this filing.
This is a standard quarterly procedural filing required by SEBI regulations and carries no material business or financial information. It is unlikely to have any impact on the stock price or shareholder value.